Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab

IMPORTANCE: Metastatic colorectal cancer (mCRC) with deficient DNA mismatch repair (dMMR) shows frequent and durable responses to programmed cell death 1 blockade. While most of these tumors are sporadic and observed in older patients, first-line pembrolizumab data are limited to findings from the K...

Descripción completa

Detalles Bibliográficos
Autores principales: Saberzadeh-Ardestani, Bahar, Jones, Jeremy C., Hubbard, Joleen M., McWilliams, Robert R., Halfdanarson, Thorvardur R., Shi, Qian, Sonbol, Mohamad Bassam, Ticku, Jonathan, Jin, Zhaohui, Sinicrope, Frank A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947726/
https://www.ncbi.nlm.nih.gov/pubmed/36811859
http://dx.doi.org/10.1001/jamanetworkopen.2023.0400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947726/
https://www.ncbi.nlm.nih.gov/pubmed/36811859
http://dx.doi.org/10.1001/jamanetworkopen.2023.0400

Ejemplares similares